| Report ID | 278714 |
| Drug Identification Number | 02244931 |
| Brand name | MESNA FOR INJECTION |
| Common or Proper name | MESNA FOR INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | MESNA |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10mL |
| ATC code | V03AF |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-04-04 |
| Actual start date | |
| Estimated end date | 2026-04-30 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-02-23 |
| Company comments | Due to production delays, we will encounter a backorder on this product effective April 4, 2026, until April 30, 2026. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-02-23 | French | Compare |
| v1 | 2026-02-23 | English | Compare |
Showing 1 to 2 of 2